15-101818736-C-T
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001001674.2(OR4F15):c.550C>T(p.Leu184Phe) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000533 in 1,614,188 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001001674.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OR4F15 | NM_001001674.2 | c.550C>T | p.Leu184Phe | missense_variant | 2/2 | ENST00000332238.5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OR4F15 | ENST00000332238.5 | c.550C>T | p.Leu184Phe | missense_variant | 2/2 | NM_001001674.2 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000309 AC: 47AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000597 AC: 15AN: 251336Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135820
GnomAD4 exome AF: 0.0000267 AC: 39AN: 1461862Hom.: 0 Cov.: 32 AF XY: 0.0000220 AC XY: 16AN XY: 727232
GnomAD4 genome AF: 0.000309 AC: 47AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000295 AC XY: 22AN XY: 74486
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 15, 2023 | The c.550C>T (p.L184F) alteration is located in exon 1 (coding exon 1) of the OR4F15 gene. This alteration results from a C to T substitution at nucleotide position 550, causing the leucine (L) at amino acid position 184 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at